ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures

SummaryALADDIN is a computer program for the design or recognition of compounds that meet geometric, steric, and substructural criteria. ALADDIN searches a database of three-dimensional structures, marks atoms that meet substructural criteria, evaluates geometric criteria, and prepares a number of files that are input for molecular modification and coordinate generation as well as for molecular graphics. Properties calculated from the three-dimensional structure are described by either properties calculated from the molecule itself or from the molecule as compared to a reference molecule and associated surfaces. ALADDIN was used to design analogues to probe a bioactive conformation of a small molecule and a peptide, to test alternative superposition rules for receptor mapping of the D2 dopamine receptor, to recognize unexpected D2 dopamine agonist activity of existing compounds, and to design compounds to fit a binding site on a protein of known structure. We have found that series designed by ALADDIN show much more subtle variation in shape than do those designed by traditional methods and that compounds can be designed to be very close matches to the objective.

[1]  Johnz Willett Similarity and Clustering in Chemical Information Systems , 1987 .

[2]  I. Kuntz,et al.  Docking flexible ligands to macromolecular receptors by molecular shape. , 1986, Journal of medicinal chemistry.

[3]  J M Blaney,et al.  A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.

[4]  David Bawden,et al.  Pharmacophoric pattern matching in files of 3d chemical structures: evaluation of search performance , 1987 .

[5]  Michael Jan. Williams,et al.  Receptor pharmacology and function , 1989 .

[6]  Ralph E. Christoffersen,et al.  Computer-assisted drug design , 1979 .

[7]  H. Rollema,et al.  Resolution of 5,6-dihydroxy-2-(N,N-di-n-propylamino)tetralin in relation to the structural and stereochemical requirements for centrally acting dopamine agonists. , 1985, Journal of medicinal chemistry.

[8]  P. Willett,et al.  Pharmacophoric pattern matching in files of 3d chemical structures: comparison of geometric searching algorithms , 1987 .

[9]  Peter Willett,et al.  Pharmacophoric pattern matching in files of 3-D chemical structures: election of interatomic distance screens , 1986 .

[10]  P. Gund,et al.  Three-dimensional molecular modeling and drug design. , 1980, Science.

[11]  Momany Fa,et al.  Conformational energy analysis of the molecule, luteinizing hormone-releasing hormone. I. Native decapeptide. , 1976 .

[12]  Mark Powell,et al.  Further examples of preferred transition state geometries in the oxidative cyclisation of indole and isoquinoline derivatives , 1981 .

[13]  Garland R. Marshall,et al.  Chapter 28. Pharmacophore Identification and Receptor Mapping , 1980 .

[14]  J G Cannon,et al.  Dopamine agonists: structure-activity relationships. , 1985, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[15]  Eric T. Sun,et al.  Amino acids derivatives that stabilize secondary structures of polypeptides , 1982 .

[16]  Andrew T. Brint,et al.  Identifying 3D maximal common substructures using Transputer networks , 1988 .

[17]  J. Nilsson,et al.  Dopamine D2 receptor binding sites for agonists. A tetrahedral model. , 1985, Molecular pharmacology.

[18]  I. Kuntz,et al.  Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure. , 1988, Journal of medicinal chemistry.

[19]  P J Goodford,et al.  Drug design by the method of receptor fit. , 1984, Journal of medicinal chemistry.

[20]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[21]  P. Goodford A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[22]  Yvonne C. Martin,et al.  MENTHOR, a database system for the storage and retrieval of three-dimensional molecular structures and associated data searchable by substructural, biologic, physical, or geometric properties , 1988, J. Comput. Aided Mol. Des..

[23]  Peter Willett,et al.  Algorithms for the identification of three-dimensional maximal common substructures , 1987, J. Chem. Inf. Comput. Sci..

[24]  B L Currie,et al.  A new approach to conformationally restricted peptide analogs: rigid beta-bends. 1. Enkephalin as an example. , 1982, Biochemical and biophysical research communications.

[25]  R Langridge,et al.  Real-time color graphics in studies of molecular interactions. , 1981, Science.

[26]  J. Bolin,et al.  Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. I. General features and binding of methotrexate. , 1982, The Journal of biological chemistry.

[27]  Garland R. Marshall,et al.  The Conformational Parameter in Drug Design: The Active Analog Approach , 1979 .